Published in Curr Hypertens Rep on September 01, 2016
Extracellular vesicles in renal disease. Nat Rev Nephrol (2017) 0.75
Alterations in antioxidant system, mitochondrial biogenesis and autophagy in preeclamptic myometrium. BBA Clin (2017) 0.75
Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women. PLoS One (2017) 0.75
Endothelial function and dysfunction: testing and clinical relevance. Circulation (2007) 6.47
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ (2005) 5.96
Pre-eclampsia: more than pregnancy-induced hypertension. Lancet (1993) 4.91
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol (2014) 3.97
Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest (1997) 3.76
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles (2013) 3.01
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 2.93
Recent Insights into the pathogenesis of pre-eclampsia. Placenta (2002) 2.91
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol (1994) 2.56
Effects of severe hypertension on endothelial and platelet microparticles. Hypertension (2003) 2.53
Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta (2009) 2.37
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res (2003) 2.15
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol (2013) 2.13
The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol (2011) 2.11
Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol (1990) 2.10
Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest (1993) 2.07
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost (2004) 1.96
Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol (2007) 1.78
Multicolor flow cytometry and nanoparticle tracking analysis of extracellular vesicles in the plasma of normal pregnant and pre-eclamptic women. Biol Reprod (2013) 1.71
Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta (2000) 1.64
Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta (2005) 1.62
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes (2002) 1.61
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ (2013) 1.56
Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol (2002) 1.55
Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol (1998) 1.55
Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood (2015) 1.55
Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol (2003) 1.54
Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol (2004) 1.51
Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol (2002) 1.47
Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest (2010) 1.43
Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J (1971) 1.39
Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One (2013) 1.36
Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol (2013) 1.33
Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2001) 1.31
Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta (2012) 1.31
Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost (2010) 1.30
Strategy for standardization of preeclampsia research study design. Hypertension (2014) 1.25
Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation (2002) 1.23
Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica (2012) 1.16
Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol (1997) 1.16
The placenta in preeclampsia. Pregnancy Hypertens (2012) 1.14
Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum (2011) 1.13
Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol (2004) 1.11
Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med (1997) 1.09
Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta (2009) 1.07
The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One (2011) 1.07
Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. PLoS One (2013) 1.05
Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol (2006) 1.05
Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam (2011) 1.05
Trophoblast- and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling. Am J Pathol (2010) 1.04
Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. J Clin Invest (2013) 1.03
Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy (2008) 1.01
Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci (2002) 0.99
Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol (2002) 0.98
Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest (1998) 0.97
Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost (2003) 0.97
Heightened pro-inflammatory effect of preeclamptic placental microvesicles on peripheral blood immune cells in humans. Biol Reprod (2012) 0.96
Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res (2012) 0.94
The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol (1995) 0.92
Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One (2011) 0.91
Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc Med (2012) 0.90
Placental extracellular vesicles and feto-maternal communication. Cold Spring Harb Perspect Med (2015) 0.90
Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol (2009) 0.89
Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost (2004) 0.89
Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost (2008) 0.89
Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm (2010) 0.88
Lipidomic analysis of human placental syncytiotrophoblast microvesicles in adverse pregnancy outcomes. Placenta (2013) 0.88
Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans. Biol Sex Differ (2015) 0.88
Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets (2007) 0.87
Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol (1993) 0.87
Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol (2012) 0.87
Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia. Int J Gynaecol Obstet (2012) 0.87
The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thromb Res (2010) 0.85
Therapeutic effects of anticoagulant agents on preeclampsia in a murine model induced by phosphatidylserine/phosphatidylcholine microvesicles. Placenta (2009) 0.85
Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clin Proteomics (2014) 0.84
Activation of human microvascular endothelial cells with TNF-alpha and hypoxia/reoxygenation enhances NK-cell adhesion, but not NK-Cytotoxicity. Transplantation (2006) 0.83
Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis (2014) 0.83
Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med (2009) 0.82
In vivo platelet activation in diabetes mellitus. Semin Thromb Hemost (1991) 0.81
Leukocyte-platelet interaction in pregnancies complicated with preeclampsia. Platelets (2005) 0.81
Circulating microparticles in severe preeclampsia. Clin Chim Acta (2012) 0.81
Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring) (2013) 0.80
Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO. Am J Physiol Heart Circ Physiol (2007) 0.80
Stimulation of monocytes by placental microparticles involves toll-like receptors and nuclear factor kappa-light-chain-enhancer of activated B cells. Front Immunol (2014) 0.80
The possible role of extravillous trophoblast-derived exosomes on the uterine spiral arterial remodeling under both normal and pathological conditions. Biomed Res Int (2014) 0.79
Macrophage Exosomes Induce Placental Inflammatory Cytokines: A Novel Mode of Maternal-Placental Messaging. Traffic (2016) 0.78
The HELLP syndrome: case report and review of the literature. J Emerg Med (1993) 0.78
Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function. PLoS One (2015) 0.77
Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction. Am J Reprod Immunol (2011) 0.76
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia. Thromb Res (2015) 0.76
CXCR4, CXCR7, and CXCL12 are associated with trophoblastic cells apoptosis and linked to pathophysiology of severe preeclampsia. Exp Mol Pathol (2015) 0.76
Detection of microparticles of leukocytic origin in the peripheral blood in normal pregnancy and preeclampsia. Bull Exp Biol Med (2014) 0.76
Influence of peripheral blood microparticles of pregnant women with preeclampsia on the phenotype of monocytes. Transl Res (2014) 0.75